Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 1
1991 1
1993 2
1995 2
1996 4
1997 3
1998 1
2000 3
2001 3
2002 4
2003 5
2004 3
2005 3
2006 2
2008 1
2012 3
2014 3
2015 2
2016 1
2017 3
2018 1
2019 1
2020 3
2021 5
2022 4
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.
Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, Mittra E, Kunz PL, Kulke MH, Jacene H, Bushnell D, O'Dorisio TM, Baum RP, Kulkarni HR, Caplin M, Lebtahi R, Hobday T, Delpassand E, Van Cutsem E, Benson A, Srirajaskanthan R, Pavel M, Mora J, Berlin J, Grande E, Reed N, Seregni E, Öberg K, Lopera Sierra M, Santoro P, Thevenet T, Erion JL, Ruszniewski P, Kwekkeboom D, Krenning E; NETTER-1 Trial Investigators. Strosberg J, et al. Among authors: delpassand e. N Engl J Med. 2017 Jan 12;376(2):125-135. doi: 10.1056/NEJMoa1607427. N Engl J Med. 2017. PMID: 28076709 Free PMC article. Clinical Trial.
Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study.
Gafita A, Calais J, Grogan TR, Hadaschik B, Wang H, Weber M, Sandhu S, Kratochwil C, Esfandiari R, Tauber R, Zeldin A, Rathke H, Armstrong WR, Robertson A, Thin P, D'Alessandria C, Rettig MB, Delpassand ES, Haberkorn U, Elashoff D, Herrmann K, Czernin J, Hofman MS, Fendler WP, Eiber M. Gafita A, et al. Among authors: delpassand es. Lancet Oncol. 2021 Aug;22(8):1115-1125. doi: 10.1016/S1470-2045(21)00274-6. Epub 2021 Jul 8. Lancet Oncol. 2021. PMID: 34246328 Free article.
Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive Review.
Askari E, Moghadam SZ, Wild D, Delpassand E, Baldari S, Nilica B, Hartrampf PE, Kong G, Grana CM, Alexander Walter M, Capoccetti F, Kasi PM, Strosberg J. Askari E, et al. Among authors: delpassand e. J Nucl Med Technol. 2023 Mar;51(1):22-25. doi: 10.2967/jnmt.122.264904. Epub 2022 Oct 4. J Nucl Med Technol. 2023. PMID: 36195446 Review.
Imaging in cervical cancer.
Follen M, Levenback CF, Iyer RB, Grigsby PW, Boss EA, Delpassand ES, Fornage BD, Fishman EK. Follen M, et al. Among authors: delpassand es. Cancer. 2003 Nov 1;98(9 Suppl):2028-38. doi: 10.1002/cncr.11679. Cancer. 2003. PMID: 14603539 Free article. Review.
Follicular thyroid cancer.
Vassilopoulousellin R, Delpassand E. Vassilopoulousellin R, et al. Among authors: delpassand e. Int J Oncol. 1996 May;8(5):969-76. doi: 10.3892/ijo.8.5.969. Int J Oncol. 1996. PMID: 21544453
Tumor Sink Effect in 68Ga-PSMA-11 PET: Myth or Reality?
Gafita A, Wang H, Robertson A, Armstrong WR, Zaum R, Weber M, Yagubbayli F, Kratochwil C, Grogan TR, Nguyen K, Navarro F, Esfandiari R, Rauscher I, Menze B, Elashoff D, Delpassand ES, Herrmann K, Czernin J, Hofman MS, Calais J, Fendler WP, Eiber M. Gafita A, et al. Among authors: delpassand es. J Nucl Med. 2022 Feb;63(2):226-232. doi: 10.2967/jnumed.121.261906. Epub 2021 May 28. J Nucl Med. 2022. PMID: 34049987 Free PMC article.
Nuclear hepatobiliary imaging.
Kim EE, Moon TY, Delpassand ES, Podoloff DA, Haynie TP. Kim EE, et al. Among authors: delpassand es. Radiol Clin North Am. 1993 Jul;31(4):923-33. Radiol Clin North Am. 1993. PMID: 8337375 Review.
62 results